Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01449539 · ClinicalTrials.gov registry record · NA
Study of Hyperbaric Oxygen Therapy in Addition to Standard Growth Factor Support for Hematopoietic Progenitor/Stem Cell Mobilization
A NA study, sponsored by University of Arkansas.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT01449539 is a NA study that was terminated before completion, run by University of Arkansas. The registered enrollment target is 8 participants.
The verdict
NCT01449539, a NA study, was terminated before completion, sponsored by University of Arkansas.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and efficacy of hyperbaric oxygen therapy (HBOT) as a therapeutic option in mobilizing stem cells for autologous stem cell transplant.
Interventions
- DRUG Hyperbaric Oxygen Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2012-02 |
| Est. Completion | 2013-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01449539
The ClinicalTrials.gov registry entry for NCT01449539 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hyperbaric Oxygen Therapy is the first listed.
NCT01449539 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01449539 about?
NCT01449539 is a clinical study titled "Study of Hyperbaric Oxygen Therapy in Addition to Standard Growth Factor Support for Hematopoietic Progenitor/Stem Cell Mobilization". The purpose of this study is to evaluate the safety and efficacy of hyperbaric oxygen therapy (HBOT) as a therapeutic option in mobilizing stem cells for autologous stem cell transplant.
What is the current status of trial NCT01449539?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2012-02. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01449539?
The interventions under investigation include: Hyperbaric Oxygen Therapy (DRUG).
Who is sponsoring clinical trial NCT01449539?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.